Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Payables (2020 - 2022)

Historic Payables for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $1.1 million.

  • Atea Pharmaceuticals' Payables fell 9496.17% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.1 million, marking a year-over-year decrease of 9496.17%. This contributed to the annual value of $4.5 million for FY2021, which is 745666.67% up from last year.
  • Per Atea Pharmaceuticals' latest filing, its Payables stood at $1.1 million for Q3 2022, which was down 9496.17% from $13.9 million recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Payables high stood at $22.2 million for Q3 2021, and its period low was $60000.0 during Q4 2020.
  • In the last 3 years, Atea Pharmaceuticals' Payables had a median value of $4.5 million in 2020 and averaged $7.2 million.
  • In the last 5 years, Atea Pharmaceuticals' Payables surged by 745666.67% in 2021 and then plummeted by 9496.17% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Payables stood at $60000.0 in 2020, then surged by 7456.67% to $4.5 million in 2021, then tumbled by 75.34% to $1.1 million in 2022.
  • Its Payables stands at $1.1 million for Q3 2022, versus $13.9 million for Q2 2022 and $3.7 million for Q1 2022.